The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma ...

The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than ...

On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma's controversial agreement that would ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

The Sackler family, owners of OxyContin maker Purdue Pharma, has agreed to pay $6 billion to settle long-running litigation alleging they fueled the nation’s opioid epidemic, The New York Times ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...